Crinetics Pharmaceuticals CRNX Total costs & expenses
Total costs & expenses at other companies
Other financials
Where this comes from
Reported directly by Crinetics Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Crinetics Pharmaceuticals's total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Crinetics Pharmaceuticals's total costs & expenses?
- Crinetics Pharmaceuticals (CRNX) reported total costs & expenses of $151.11M in Q1 2026.
- How has Crinetics Pharmaceuticals's total costs & expenses changed year-over-year?
- Crinetics Pharmaceuticals's total costs & expenses increased by 35.2% year-over-year, from $111.77M to $151.11M.
- What does total costs & expenses mean?
- This represents the aggregate sum of all operating and non-operating costs incurred by the company during a reporting period, including research and development, selling, general, and administrative expenses. It serves as a primary indicator of the company's total burn rate and operational scale. Monitoring this metric is essential for assessing the efficiency of resource allocation in a clinical-stage pharmaceutical environment.